Meet Our Speakers
Discover the brilliant minds behind our event. Explore the profiles of our speakers, their expertise, and the unique insights they bring to inspire and engage our audience.

Maria Barbu
Senior Medical Oncologist and Assistant Professor in the Department of Oncology at Carol Davila University of Medicine and Pharmacy in Bucharest. She has extensive experience in the multidisciplinary management of cancer patients and is actively involved in both clinical practice and medical education. Dr. Barbu is a member of ESMO, ASCO, and the European Association of Urology (EAU), and serves on the Urogenital Cancers Working Group of the Romanian Society of Medical Oncology (SNOMR). Her professional interests focus on advancing cancer care through evidence-based practice, medical education, and continuous professional development in modern oncology.

Mihai Stoicea
Pathologist and molecular pathology expert with extensive experience in digital pathology, AI-assisted diagnostics, and molecular testing. He has been actively involved in the development and implementation of innovative diagnostic solutions and digital transformation projects in pathology, with a strong interest in precision medicine and connectivity in healthcare systems.

Nina Tunariu
Consultant Radiologist at Royal Marsden Hospital, UK as the dedicated Radiologist for the Drug Development Unit and Prostate Cancer Targeted Therapy Clinical Trials Team.
Dr Nina Tunariu qualified from the University of Medicine “luliu Hatieganu” in Romania, completed general medical training at Imperial NHS Trust, Papworth NHS Hospital and Royal London Hospital and her Clinical Radiology training at Imperial College NHS Trust. In October 2008, Dr Tunariu joined Institute of Cancer Research and Royal Marsden Hospital to undertake an Oncological Imaging Fellowship; in 2014 she was awarded an MDRes for the thesis entitled “Standardisation of Data Analysis Methods for Multiparametric MRI in phase I clinical trials” by University of London.
Dr Tunariu’s clinical and research interests include the integrated application of multimodality whole body imaging for evaluation of intra and inter-patient heterogeneity in advanced prostate cancer with a focus on translation of whole-body MRI as tumour response tool in clinical practice.

Nelly Cherciu
Medical Oncologist at St. Nectarie Oncology Center, Craiova, Romania. Dr. Cherciu has extensive experience in the management of solid tumors and has been actively involved in phase II-IV clinical trials across multiple oncology indications, including lung, breast, colorectal, ovarian, and prostate cancers. Her professional interests focus on improving patient outcomes through clinical research and evidence-based oncology practice.

Alison Birtle
Consultant Clinical Oncologist at Rosemere Cancer Centre, Lancashire Teaching Hospitals, and Honorary Clinical Professor at the University of Manchester and University of Central Lancashire, specializing in urological cancers.
Internationally recognized expert, actively involved in guideline development and clinical research, including as Chief Investigator of the practice‑changing POUT trial.
Awarded multiple prestigious distinctions, including the NHS “70 Stars” award and Researcher of the Year at the North West Coast Health & Innovation Awards.

Amedeia Niță
Senior Medical Oncologist based in Ploiești, Romania, with extensive experience in the management of patients with solid tumors. She is actively involved in multidisciplinary cancer care and works closely with specialists across different disciplines to optimize treatment strategies and patient outcomes. Her professional interests include personalized treatment approaches, evidence-based oncology, and the integration of emerging therapeutic advances into routine clinical practice. She has contributed to numerous scientific publications and presentations in prostate cancer and uro-oncology and has extensive clinical research experience as both Principal Investigator and Sub-Investigator in international clinical trials. She is committed to advancing high-quality cancer care and improving outcomes for patients through a collaborative, patient-centered approach.

Adina Nemeș
Senior Medical Oncologist at the “Prof. Dr. Ion Chiricuță” Oncology Institute and Assistant Professor at the “Iuliu Hațieganu” University of Medicine and Pharmacy in Cluj-Napoca, Romania. Her clinical and academic interests include genitourinary malignancies, with a particular focus on prostate and bladder cancer. She has contributed to numerous scientific publications and presentations in prostate cancer and uro-oncology and has extensive clinical research experience as both Principal Investigator and Sub-Investigator in international clinical trials. Dr. Nemeș is also actively involved in medical education and multidisciplinary oncology care.

Raluca Mihăilă
Senior Medical Oncologist at the Prof. Dr. Alexandru Trestioreanu Institute of Oncology in Bucharest, Romania. She has extensive experience in the management of solid tumors and is actively involved in clinical research as both principal investigator and sub-investigator in national and international clinical trials. Dr. Mihăilă is a member of ESMO, ASCO, and SNOMR, with a particular interest in personalized oncology, molecular diagnostics, targeted therapies, and immuno-oncology.

Laura Mazilu
Is a senior medical oncologist, internal medicine specialist and Professor of Oncology at Ovidius University of Constanța. She is Head of the Clinical Oncology Department at Ovidius Clinical Hospital and coordinates the National Oncology Program’s treatment subprogram. Her career spans more than 25 years in oncology, including departmental leadership at the Constanța County Emergency Clinical Hospital and long-standing coordination of oncology residency training.
She is President of the Romanian Society for Medical Oncology for 2026–2027 and has held senior roles in national oncology bodies and specialist commissions.
Her principal clinical and research interests include thoracic and breast oncology, biomarkers, targeted therapies and immunotherapy, cardio-oncology, and multicenter clinical research. She has an extensive scientific record, including peer-reviewed publications, book chapters, invited presentations and work as principal investigator in more than 30 clinical trials.

Michael Schenker
Is a senior medical oncologist, Head of Medical Oncology in Craiova, and Associate Professor of Oncology, with over 20 years of experience and a particular focus on lung cancer. He holds major national leadership roles as President of the Ministry of Health’s Medical Oncology Commission and of the working group implementing Romania’s National Cancer Control Plan. As Principal Investigator in more than 300 international clinical trials, he has contributed to advances in thoracic oncology and systemic cancer therapies. His academic record includes 160 ISI-indexed publications, more than 17,000 citations, an H-index over 40, and over 100 congress presentations. He is also the Founder and Director of the St. Nectarios Oncology Center, which integrates comprehensive care, clinical research, and medical education.

Mircea Dediu
Is the Head of the Medical Oncology Department at the NORD Hospital in Bucharest. He served as Romanian National Representative to ESMO during 2003-2011. He was accepted as full member of ESMO, ASCO, IASLC, and EORTC. Dr. Dediu is deeply
Confidential
involved in the research work, specifically in the lung cancer field, where he activated as principal investigator in more than 35 international multicenter clinical trials. His scientific work includes more than 30 articles published in international journals like the New England Journal of Medicine, Journal of Clinical Oncology, Annals of Oncology, Lung Cancer, and Journal of BUON. More than 25 personal communications were accepted for presentation (oral or poster) in prestigious international congresses like ASCO, ESMO, ECCO, IASLC, BUON and others. Dr. Dediu is member of the Editorial Board and permanent reviewer for “magazine of european medical oncology (memo)” and Journal of BUON. He is also recognized as a major contributor in many educational activities. He was invited to deliver oral presentations and to chair scientific sessions in various international and domestic conferences. His educational activities were highly appreciated by the attendants and the members of the organizing committees.

Liliana Popa
Is a faculty member in the Department of Dermatology at the “Carol Davila” University of Medicine and Pharmacy in Bucharest. She is a senior specialist dermatologist and venereologist at the Elias University Emergency Hospital. She is actively involved in the management of patients with malignancies working closely with the Oncology Department of Elias University Emergency Hospital.
Her research portfolio includes participation in projects and multicenter clinical trials covering topics such as psoriasis, atopic dermatitis, and other areas of major interest in current dermatological practice, complemented by scientific evaluation work as a reviewer for specialized publications.
She has extensive editorial expertise as an author and co-author of numerous internationally and nationally published textbooks, textbook chapters, and monographs
